focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.00
Ask: 46.00
Change: 0.50 (1.12%)
Spread: 2.00 (4.545%)
Open: 44.50
High: 45.00
Low: 44.50
Prev. Close: 44.50
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Eneraqua shares plunge on annual profit warning

Wed, 11th Oct 2023 10:52

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Power Metal Resources PLC, up 8.8% at 0.68 pence, 12-month range 0.55-1.85p. The metals exploration and development company reports that extensive radon gas sampling at the Tait Hill and Soaring Bay projects in and around the Athabasca Basin in Saskatchewan, Canada, have confirmed multiple significant uranium targets. Chief Executive Sean Wade says this season's uranium fieldwork continues to surpass the firm's expectations in terms of quality and number of significant targets discovered. "Following very low acquisition costs, we believe we are now adding very considerable value to a portfolio with well thought out, methodical and inexpensive exploration, clearly demonstrating the ongoing success of our business model. We now look forward to the next stage, that of crystallising the value created for our shareholders. We are in discussion with various third parties about ways in which we can do that, and I look forward to updating shareholders on those discussions in due course," the CEO adds.

----------

Cambridge Cognition Holdings PLC, up 6.7% at 74.70 pence, 12-month range 65.35-129.74p. The company wins a "significant" GBP1 million contract for a "sizeable" later stage clinical trial, following a competitive tender. The contract combines the company's Cantab touch-screen cognitive assessments with verbal assessments from its recent Winterlight Labs acquisition. Cambridge Cognition will supply its electronic clinical outcome assessments and provide full training for clinicians, together with quality control services, as part of the contract. Revenue from the contract is expected to be recognised over a two-year period, starting in 2023. Notes there is potential for a further contract with the same customer, of "slightly" higher value, in 2024 once the initial results have been analysed. Cambridge Cognition develops and markets digital solutions to assess brain health.

----------

AIM - LOSERS

----------

Eneraqua Technologies PLC, down 58% at 39.00 pence, 12-month range 38.26-389.60p. The energy and water efficiency solution provider swings to an interim loss amid rising costs and warns of a "material reduction" in profitability in the full-year. Pretax loss in the six months ended July 31 totals GBP441,000, swinging from a profit of GBP3.0 million the year prior. Loss comes as the company records a 20% rise in its cost of sales to GBP17.2 million, and a 31% rise in administrative expenses to GBP9.0 million. The rising costs offsets growth in revenue which rises 7.4% to GBP26.0 million from GBP24.2 million. Chief Executive Mitesh Dhanak adds: "Post-period end the group has faced dual headwinds. The continued and increased budgetary pressures on local government are leading to discussions on slowing down project delivery and deferring works into [financial 2025]. This compounds the impact of the recent unexpected [UK] government policy change in relation to net nutrient neutrality. As a result, the board now expects some projects to be delivered more slowly with revenues moving into next year and reduced operational leverage affecting margins. As a result we expect to see a material reduction in revenues and outturn in profitability during [financial 2024]."

----------

Jubilee Metals Group PLC, down 11% at 6.26 pence, 12-month range 6.01-13.92p. The metal processing company reports that its annual profit more than halved as surging overhead costs put margins under pressure. Posts a pretax profit of GBP12.3 million in the financial year ended June 30, down 54% from GBP26.5 million a year earlier. Profit margins shrink to 22% from 32%, as costs balloon. Cost of sales grow by 17% to GBP110.5 million from GBP94.6 million. Finance costs multiply to GBP5.2 million from GBP1.4 million. Jubilee reports revenue of GBP141.9 million, up slightly 1.4% from GBP140.0 million, with growth in dollar-denominated chrome revenue predominately offsetting a decrease in platinum group metal revenue. Notes that PGM price is now trading at USD1,359 an ounce, which is 46% below the 2022 financial average and 21% below average in the 2023 financial year.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
20 Sep 2018 12:35

Cambridge Cognition Holdings Loss Widens As Revenue Drops

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that its loss for the first half of the financial year widened as it recorded a drop in revenue as a result of the new IFRS

Read more
19 Sep 2018 12:45

Cambridge Cognition To Provide NeuroVocalix For Virtual Clinical Tests

LONDON (Alliance News) - Cambridge Cognition Holdings PLC on Wednesday said it signed its first commercial contract with an undisclosed pharmaceutical firm for its recently launched NeuroVocalix a

Read more
19 Sep 2018 10:14

Cambridge Cognition announces first NeuroVocalix commercial partnership

(Sharecast News) - Neuroscience technology company Cambridge Cognition Holdings announced its first commercial partnership for its recently launched 'NeuroVocalix' voice biomarker technology on Wednesday.

Read more
13 Sep 2018 11:14

Cambridge Cognition's NeuroVocalix Set For Clinical Trial Use

LONDON (Alliance News) - Neuroscience technology firm Cambridge Cognition Holdings PLC on Thursday said its NeuroVocalix platform is ready for clinical trials.NeuroVocalix, the company to a

Read more
1 Aug 2018 11:51

Cambridge Cognition Inks US Production Distribution For CANTAB

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Wednesday that it signed a commercial collaboration with health provider Healthy Amplified to launch its software product to better a

Read more
17 May 2018 16:01

UK Shareholder Meetings Calendar - Next 7 Days

Friday 18 MayPaddy Power BetfairIndependent News & (T)PetrofacJohn Group (re by

Read more
22 Mar 2018 13:03

Cambridge Cognition Shares Fall As It Swings To Annual Loss

LONDON (Alliance News) - Shares fell in Cambridge Cognition Holdings PLC on Thursday as it swung to a loss in 2017 from a maiden profit due to higher costs and lower in the at

Read more
14 Mar 2018 12:47

Oil majors give in to investors with share buyback spree

By Nivedita Bhattacharjee March 14 (Reuters) - After almost three barren years for investors who have poured millions into the U.S. oil sector, producers are finally to

Read more
25 Jan 2017 08:27

Cambridge Cognition gains US regulatory approval for memory test

(ShareCast News) - Neuroscience digital health company Cambridge Cognition has gained regulatory clearance for its memory test to be used as a medical device in the US. Cantab Mobile, which detects clinically-relevant memory impairment in older adults at the point of care, received 510k clearance fo

Read more
13 Oct 2016 10:55

Cambridge Cognition confirms series of new contracts

(ShareCast News) - Neuroscience company Cambridge Cognition Holdings announced a series of new contracts worth more than £0.25m on Thursday, to assess - through CANTAB Connect - the abuse potential of investigational drugs in a new market application for the company. The AIM-traded firm claimed that

Read more
22 Sep 2016 10:23

Cambridge Cognition's sales up after investments in marketing

(ShareCast News) - Cambridge Cognition' half-year revenues grew and losses were more than halved as the neuroscience software and hardware company's invested in marketing and development. For the six months ended 30 June, revenue increased by 11.3% to £3.26, compared to the same period last year. T

Read more
22 Sep 2016 08:51

Cambridge Cognition Loss Narrows On Strong Revenue Growth

Read more
20 Sep 2016 08:07

Cambridge Cognition Inks First Contract For CANTAB Recruit Product

Read more
16 Aug 2016 13:49

Cambridge Cognition announces promising results from technology study

(ShareCast News) - Neuroscience company Cambridge Cognition Holdings announced results on Tuesday from a new technology feasibility study. The AIM-traded firm, which develops and markets near-patient technologies for the assessment of brain health to improve the drug development process, said the re

Read more
20 Jul 2016 07:49

Cambridge Cognition Signs GBP500,000 CANTAB Deal With Biobank

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.